Cytosolic Prostaglandin E Synthase: Expression Patterns in Control and Alzheimer's Disease Brains

被引:9
作者
Chaudhry, Uzma A. [1 ]
Dore, Sylvain [1 ]
机构
[1] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Sch Med, Baltimore, MD 21205 USA
来源
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS | 2009年 / 24卷 / 01期
关键词
cyclooxygenase; drug development; eicosanoid; human; inflammation; prostaglandin E-2; E-2; SYNTHASE; DOWN-REGULATION; PHOSPHORYLATION; IDENTIFICATION; RECEPTOR; NEURONS; RATS; PAIN;
D O I
10.1177/1533317508323655
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Anti-inflammatory drugs reduce the risk of Alzheimer's disease but fail to slow its progression. Studying the expression of prostaglandin E-2 synthases downstream of cyclooxygenase-2 is important. Here, the expression patterns of cytosolic prostaglandin E-2 synthases, an immediate prostaglandin E-2 source was investigated. Sections taken from the middle frontal gyrus of brains of 10 patients with Alzheimer's and 5 age-matched controls were examined by immunostaining for the presence of the synthases. Immunofluorescence analysis of control brains showed that cytosolic prostaglandin E-2 synthases co-localize with microglia, neurone, and endothelium markers, but not with astrocytes or smooth muscle cells. Immunohistochemical staining for the synthases was positive in the pyramidal neurons of controls but barely detectable in the brain of Alzheimer's patients. These findings revealed that cytosolic prostaglandin E-2 synthases is found in microglia, neurons, and endothelium of control human middle frontal gyrus and that its levels decrease in pyramidal cells of Alzheimer's disease brains.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 26 条
[1]  
Allen Institute for Brain Science, ALL BRAIN ATL
[2]   NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation [J].
Amadoro, G ;
Ciotti, MT ;
Costanzi, M ;
Cestari, V ;
Calissano, P ;
Canu, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (08) :2892-2897
[3]  
Angenstein F, 1999, HIPPOCAMPUS, V9, P173, DOI 10.1002/(SICI)1098-1063(1999)9:2<173::AID-HIPO8>3.0.CO
[4]  
2-K
[5]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]  
CHAUDHRY U, 2008, ALZHEIMERS IN PRESS
[7]   Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease [J].
Combrinck, M ;
Williams, J ;
De Berardinis, MA ;
Warden, D ;
Puopolo, M ;
Smith, AD ;
Minghetti, L .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (01) :85-88
[8]   Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure [J].
Echeverria, V ;
Clerman, A ;
Doré, S .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (09) :2199-2206
[9]  
GREENWOOD JA, 1994, J BIOL CHEM, V269, P4373
[10]   Interleukin-1 mediates Alzheimer and Lewy body pathologies [J].
Griffin, W. Sue T. ;
Liu, Ling ;
Li, Yuekui ;
Mrak, Robert E. ;
Barger, Steven W. .
JOURNAL OF NEUROINFLAMMATION, 2006, 3 (1)